Age-Specific Associations of Moderate-to-Vigorous Physical Activity With Relative and Absolute Risk of Type 2 Diabetes in UK Biobank Participants.

IF 6.1 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Diabetes, Obesity & Metabolism Pub Date : 2026-11-01 Epub Date: 2026-08-13 DOI:10.1111/dom.71214
Qiuyu Feng, Raymond Noordam, Denghui Hu, Gali Albalak, Ko Willems van Dijk, Diana van Heemst
{"title":"Age-Specific Associations of Moderate-to-Vigorous Physical Activity With Relative and Absolute Risk of Type 2 Diabetes in UK Biobank Participants.","authors":"Qiuyu Feng, Raymond Noordam, Denghui Hu, Gali Albalak, Ko Willems van Dijk, Diana van Heemst","doi":"10.1111/dom.71214","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>We assessed the age-specific associations between moderate-to-vigorous physical activity (MVPA) and incident type 2 diabetes.</p><p><strong>Materials and methods: </strong>We included UK Biobank participants with valid accelerometry data without diabetes mellitus at baseline (N = 87 975; 62.7 years [IQR, 55.6-67.9]; 57% women). We examined whether age, sex and baseline metabolic disease status modified the associations of MVPA volume (lower versus higher) and, in exploratory analyses, MVPA timing (later-day versus earlier-day) with incident type 2 diabetes. Age-specific relative and absolute associations were assessed across 5-year age bins using hazard ratios (HRs) and incidence rate differences (IRDs), and additionally stratified by sex and baseline metabolic disease status.</p><p><strong>Results: </strong>Associations of MVPA volume with type 2 diabetes were most consistently modified by age, baseline prediabetes (all p-values for interaction < 0.05), with stronger associations observed among participants younger than the median population age (< 62.7 years, HR = 2.44 [95% CI: 2.05-2.90] versus HR = 1.65 [95% CI: 1.47-1.86]) and participants without prediabetes. Across 5-year age groups, HRs declined with age, whereas IRDs increased in the overall population. No clear effect modification was observed for the association between MVPA timing and type 2 diabetes risk.</p><p><strong>Conclusions: </strong>The relative association between higher MVPA volume and lower type 2 diabetes risk attenuated with age and was weaker among individuals with prediabetes, whereas absolute risk reductions were larger among older and metabolically higher-risk individuals. These findings support considering both relative and absolute measures when targeting MVPA interventions for type 2 diabetes prevention.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":"10099-10109"},"PeriodicalIF":6.1000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646361/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.71214","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: We assessed the age-specific associations between moderate-to-vigorous physical activity (MVPA) and incident type 2 diabetes.

Materials and methods: We included UK Biobank participants with valid accelerometry data without diabetes mellitus at baseline (N = 87 975; 62.7 years [IQR, 55.6-67.9]; 57% women). We examined whether age, sex and baseline metabolic disease status modified the associations of MVPA volume (lower versus higher) and, in exploratory analyses, MVPA timing (later-day versus earlier-day) with incident type 2 diabetes. Age-specific relative and absolute associations were assessed across 5-year age bins using hazard ratios (HRs) and incidence rate differences (IRDs), and additionally stratified by sex and baseline metabolic disease status.

Results: Associations of MVPA volume with type 2 diabetes were most consistently modified by age, baseline prediabetes (all p-values for interaction < 0.05), with stronger associations observed among participants younger than the median population age (< 62.7 years, HR = 2.44 [95% CI: 2.05-2.90] versus HR = 1.65 [95% CI: 1.47-1.86]) and participants without prediabetes. Across 5-year age groups, HRs declined with age, whereas IRDs increased in the overall population. No clear effect modification was observed for the association between MVPA timing and type 2 diabetes risk.

Conclusions: The relative association between higher MVPA volume and lower type 2 diabetes risk attenuated with age and was weaker among individuals with prediabetes, whereas absolute risk reductions were larger among older and metabolically higher-risk individuals. These findings support considering both relative and absolute measures when targeting MVPA interventions for type 2 diabetes prevention.

在英国生物银行参与者中,中等至剧烈体育活动与2型糖尿病的相对和绝对风险的年龄特异性关联
目的:我们评估了中等至剧烈体育活动(MVPA)与2型糖尿病发病之间的年龄特异性关联。材料和方法:我们纳入了具有有效加速度计数据且基线时无糖尿病的UK Biobank参与者(N = 87975; 62.7岁[IQR, 55.6-67.9]; 57%为女性)。我们研究了年龄、性别和基线代谢疾病状态是否改变了MVPA体积(低与高)的关系,并在探索性分析中,研究了MVPA时间(晚些时候与早些时候)与2型糖尿病的关系。使用风险比(hr)和发病率差异(IRDs)评估5年年龄组中特定年龄的相对和绝对相关性,并根据性别和基线代谢疾病状态进行分层。结果:MVPA体积与2型糖尿病的相关性最一致地受到年龄、基线前驱糖尿病(相互作用的所有p值)的影响。结论:MVPA体积高与2型糖尿病风险低之间的相对相关性随着年龄的增长而减弱,在前驱糖尿病个体中较弱,而在年龄较大和代谢高风险个体中绝对风险降低较大。这些发现支持在针对MVPA干预预防2型糖尿病时考虑相对和绝对措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书